semaglutide fda label Oral Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA approves Ozempic® (semaglutide) as
Description
Consult with your physician before starting GLP-1 or any new exercise program

Discover the best Weight Watchers in Best Sellers

Our medical weight loss center in Wichita Falls will motivate, encourage, and boost your confidence all while you reach your weight loss goals!

Rated 4.5/5

Pregnant or planning

Obesity affects over 1.9 billion people worldwide.[1]In 2024, global spend on anti-obesity medication exceeded $30 billion for the first time, which is over a ten-fold increase since 2020, as reported by IQVIA.[2]This is driven by an unprecedented and ever-increasing demand for appetite-suppressing drugs, with Novo Nordisk being a leader in the research, development and manufacture []
:max_bytes(150000):strip_icc():focal(710x110:712x112)/FDA-Updates-Ozempi-Label-Amid-Concerns-Over-Intestinal-Blockages-Linked-to-Semaglutide-Based-Drugs-092923-c374c02352e2400ea820da6d0cf2abc5.jpg)